Andrés Aguilar Hernandez, Manuel Cobo, Alexandra Cantero, Antonio Calles, Rosa Álvarez Álvarez, Aitor Azkarate, Raquel Marse Fabregat, Emiliano Agüero, Alejandro Martinez-Bueno, María González-Cao, Ivana Gabriella Sullivan, Miguel Angel Molina Vila, Rafael Rosell. "Osimertinib plus repotrectinib phase I trial in TKI-resistant non-small cell lung cancer (NSCLC) with EGFR mutations.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8604